Shake It Up Supporting New Trial of Anavex 2-73 in Parkinson’s Patients
The Shake It Up Australia Foundation for Parkinson’s Research, together with its partners worldwide, has pledged to cover up…
Articles by David Melamed, PhD
Novant Health to Offer MR-guided Focused Ultrasound to Treat Tremors
Novant Health announced that it will soon be the first healthcare provider in the Carolinas to offer an incision-free brain “surgery”…
Anle138b Seen as Safe and Moving to Patient Trial With MJFF Support
The small molecule anle138b has shown “excellent” safety and tolerability profiles in a first study in healthy volunteers, and…
Denali, Biogen Partner to Move DNL151 Into Late-stage Parkinson’s Trials
Denali Therapeutics announced a partnership with Biogen to jointly develop and advance DNL151, an investigational small molecule treatment for…
Parkinson’s UK Invests £1M More Into Work to Protect Mitochrondria
The nonprofit Parkinson’s UK announced an additional £1 million (about $1.3 million) award to NRG Therapeutics, advancing its work…
MJFF Awards $8.5M to 3 Teams Working to Image Protein Clumps
The Michael J. Fox Foundation (MJFF) has awarded a total of $8.5 million to research teams at AC…
Axial Given $440K Grant to Develop Model for Studies of Gut-Brain Axis
Axial Biotherapeutics announced a $440,000 grant from the Michael J. Fox Foundation for Parkinson’s Research to support its efforts…
Abbott Earns FDA Approval for iOS App to Manage Personalized Neuromodulation Therapy
The U.S. Food and Drug Administration (FDA) has approved a new app developed by Abbott, called the Patient…
Salmonella Can Form Biofilms, May Be Tied to Disease via Autoimmune Reaction
Pathogenic bacteria such as Salmonella typhimurium were seen for a first time to form biofilms, or dense clusters of…
Seelos Begins Animal Study Investigating SLS-007 as Parkinson’s Treatment
Seelos Therapeutics has begun a preclinical study in rodents to test a gene therapy approach to deliver its investigational…